Published

Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Exploration of neuroscience
Date: 2024-09-24
Source: OpenAlex
DOI: 10.37349/en.2024.00058
PubMed: Unavailable

Authors

Bushra Yasin Shivani Mehta George Tewfik Alex Bekker

Watch author

Derived topics and classifications

psilocybin Addiction Chronic Pain Neuroplasticity Pharmacology Mechanism of Action Receptor Pharmacology Emotional Processing Spirituality Review Article Inflammation Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Psychedelics as novel therapeutic agents for chronic pain: mechanisms and future perspectives2024-09-24

Related papers

Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 Psilocybin as a novel treatment for chronic pain.British journal of pharmacology · 2026-07-01 Psilocybin produces amplified acute responses and sex-specific long-term increases in sensorimotor gating in the mGlu5 knockout mouse model of schizophreniaNeuropsychopharmacology · 2026-07-18 Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06 A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24